Hubei Biocause Pharmaceutical Co., Ltd. announced on 24 April 2023 the final profit distribution proposal for 2022 as Cash dividend/10 shares (tax included): CNY 1.10000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 CNY | +1.08% | -4.57% | -33.80% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.80% | 1.28B | |
-0.20% | 69.29B | |
+5.50% | 49.46B | |
+3.66% | 48.75B | |
+17.83% | 44.91B | |
+18.24% | 37.4B | |
+20.40% | 34.09B | |
-4.92% | 27.56B | |
-10.60% | 26.6B | |
+27.21% | 26.35B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Hubei Biocause Pharmaceutical Co., Ltd. Announces Final Profit Distribution Proposal for 2022